Ani Pharmaceuticals reported $286.31M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Aerie Pharmaceuticals AERI:US $ 312.13M 0.45M
Aurora Cannabis Inc ACB:CN 343.55M 26.3M
Canopy Growth Corp WEED:CN C$ 1.26B 270.14M
Depomed DEPO:US $ 49.5M 11.75M
Eli Lilly And LLY:US $ 14692M 460.9M
Emergent Biosolutions EBS:US $ 793.6M 7.9M
Hikma Pharmaceutical HIK:LN 1.41B 689M
Knight Therapeutics Inc GUD:CN C$ 11.86M 2.11M
Lannett LCI:US $ 610.08M 6.6M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 23784M 589M
Perrigo Ordinary Shares PRGO:US $ 4086.1M 575.5M
Teva Pharmaceutical TEVA:IT 20.36B 477M
Teva Pharmaceutical Industries TEVA:US $ 20363M 477M